Skip to content

Repligen RGEN Investment Income

Investment Income at other companies

Ispire Technology Inc. logo
Ispire Technology Inc.ISPR
$10M
CHE
ChemedCHE
$890K-57.1%
Main Street Capital logo
Main Street CapitalMAIN
$84.58M-1.5%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$20.23M-18.1%
Capital Southwest logo
Capital SouthwestCSWC
$34.61M+24.3%
Blue Owl Technology Finance Corp. logo
Blue Owl Technology Finance Corp.OTF
$171.31M+76.0%

Other financials

Income statement

See full
Revenue$204.1M+11.9%
Gross profit$110.0M+20.7%
Operating income$14.0M+0.6%
Net income$5.0M-66.3%
EPS (diluted)$0.09-65.4%

Balance sheet

See full
Cash & equivalents$606.8M-14.4%
Total debt$690.9M+354%
Total equity$2.1B+2.4%
Total assets$3.0B+1.7%

Cash flow

See full
Operating cash flow$32.8M+14.5%
CapEx$5.3M-24.9%
Free cash flow$27.4M+27.5%

Valuation

See full
Market cap$7.39B+10.0%
Enterprise value$7.48B+21.3%
P/E178×
P/S9.6×+0.3×

Profitability

See full
Gross margin47.6%+0.9pp
Operating margin15.6%-11.0pp
Net margin17.3%-3.5pp
FCF margin22%+6.9pp

Returns & leverage

See full
Return on equity2%+1.6pp
Debt / equity0.3×+0.3×
Current ratio9.1×+0.5×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.

The official record: Repligen’s 10-Q, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's investment income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's investment income?
Repligen (RGEN) reported investment income of $6.43M in Q2 2026.
How has Repligen's investment income changed year-over-year?
Repligen's investment income decreased by 2.3% year-over-year, from $6.59M to $6.43M.
What is the long-term trend for Repligen's investment income?
Over 2 years (2021 to 2023), Repligen's investment income has grown at a 1071.0% compound annual growth rate (CAGR), from $176K to $24.14M.